热门资讯> 正文
Vista Healthcare业务报告导致Chemed股价下跌
2026-08-28 02:33
- Chemed (CHE) fell 4.6% amid a report about the company's Vista Healthcare business.
- The report was published by the Capitol Forum, according to a post on X on Thursday.
- Chemed (CHE) didn't immediately respond to a Seeking Alpha request for comment.
- Chemed, which is the target of activist investor Barington Capital, has short interest of 3.5%. Barington last month said it wants the hospice service and Roto-Rooter owner to start a strategic review and change its board.
More on Chemed
- Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value
- Chemed Corporation (CHE) Q2 2026 Earnings Call Transcript
- Chemed Corporation 2026 Q2 - Results - Earnings Call Presentation
- Chemed forecasts 2026 EPS of $25-$25.75 as VITAS targets 5.75%-6.25% ADC growth
- Chemed Q2 2026 Earnings Preview
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。